1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics, November 2016 (p50)

Therapy Analysis & Statistics, November 2016 (p50)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

1471-1500 of about 8200 reports

Purchase Reports From Reputable Market Research Publishers

Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Pipeline Review, H2 2016

Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cyclin Dependent ...

  • Industries : Therapy, Cancer, Pathology, Oncology
  • Countries : United States
Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Pipeline Review, H2 2016

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Low Affinity Immunoglobulin Gamma ...

  • Industries : Pathology, Therapy
  • Countries : United States
Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016’, provides in depth analysis on Human ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology, Biological Therapy
  • Countries : United States
Migraine - Pipeline Review, H2 2016

Migraine - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Migraine - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine – Pipeline Review, H2 2016, provides an overview of the Migraine ...

  • Industries : Pharmaceutical, OTC, Therapy
  • Countries : United States
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections – Pipeline ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Thrombopoietin Receptor (Myeloproliferative ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : Europe, World
Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H2 2016

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H2 ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States
Cancer Pain - Pipeline Review, H2 2016

Cancer Pain - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cancer Pain - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain – Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology, Cancer, Therapy, Pharmaceutical
  • Countries : United States
Escherichia coli Infections - Pipeline Review, H2 2016

Escherichia coli Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Escherichia coli Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Escherichia coli Infections – Pipeline Review, H2 2016, ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States, World
Melasma (Chlosma) - Pipeline Review, H2 2016

Melasma (Chlosma) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Melasma (Chlosma) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melasma (Chlosma) – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pharmaceutical, Therapy, Drug Discovery and Development
  • Countries : World
Hypercholesterolemia - Pipeline Review, H2 2016

Hypercholesterolemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Hypercholesterolemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia – Pipeline Review, H2 2016, provides an ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical
  • Countries : United States
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States
Osteonecrosis - Pipeline Review, H2 2016

Osteonecrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Osteonecrosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Therapy
  • Countries : United Kingdom, World
Cervical Cancer - Pipeline Review, H2 2016

Cervical Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cervical Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States
Analgesics in Estonia

Analgesics in Estonia

  • $ 912
  • Industry report
  • November 2016
  • by Euromonitor International

Based on active substances, analgesics could be divided to three main categories - ibuprofen, acetaminophen (paracetamol) and acetylsalicylic acid (aspirin). Ibuprofen has taken the lead and paracetamol ...

  • Industries : OTC
  • Countries : Estonia
Alcohol Addiction Global Clinical Trials Review, H2, 2016

Alcohol Addiction Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Alcohol Addiction Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Alcohol Addiction Global Clinical Trials Review, H2, 2016" provides an overview of Alcohol Addiction ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World, United States
Tardive Dyskinesia Global Clinical Trials Review, H2, 2016

Tardive Dyskinesia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Tardive Dyskinesia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H2, 2016" provides an overview of Tardive Dyskinesia ...

  • Industries : Mental Health, Pathology, Therapy, Pharmaceutical
  • Countries : World
Brain Hemorrhage Global Clinical Trials Review, H2, 2016

Brain Hemorrhage Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Brain Hemorrhage Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H2, 2016" provides an overview of Brain Hemorrhage ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Osteoarthritis Global Clinical Trials Review, H2, 2016

Osteoarthritis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Osteoarthritis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H2, 2016" provides an overview of Osteoarthritis clinical ...

  • Industries : Pharmaceutical, Drug Discovery and Development
  • Countries : World
Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2016

Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2016" provides an ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World
Brain Ischemia Global Clinical Trials Review, H2, 2016

Brain Ischemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Brain Ischemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Brain Ischemia Global Clinical Trials Review, H2, 2016" provides an overview of Brain Ischemia clinical ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Tension -Type Headache Global Clinical Trials Review, H2, 2016

Tension -Type Headache Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Tension -Type Headache Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Tension -Type Headache Global Clinical Trials Review, H2, 2016" provides an overview of Tension ...

  • Industries : OTC, Pharmaceutical, Therapy, Chronic Disease
  • Countries : World
Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016

Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016" provides an ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : World
Radiculopathy Global Clinical Trials Review, H2, 2016

Radiculopathy Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Radiculopathy Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H2, 2016" provides an overview of Radiculopathy clinical ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical
  • Countries : World
Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016 - 2026

Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016 - 2026

  • $ 2349
  • Industry report
  • November 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Rheumatoid Arthritis (RA) is an autoimmune, inflammatory disorder wherein various components of the immune system begin to attack the body’s own cells and tissues. The disease is characterized ...

  • Industries : Pharmaceutical, Therapy, Chronic Disease, Drug Discovery and Development, Pathology
  • Countries : United States
Global Lung Cancer Therapeutics Market 2016-2020

Global Lung Cancer Therapeutics Market 2016-2020

  • $ 2500
  • Industry report
  • November 2016
  • by Infiniti Research Limited

About Lung Cancer Therapeutics Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming

Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming

  • $ 2349
  • Industry report
  • November 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Since the discovery of penicillin in 1948, antibiotics have emerged as a crucial class of pharmacological interventions responsible for treating several infectious conditions. In addition, ...

  • Industries : Therapy, Pharmaceutical
  • Countries : Europe, World
Diabetic Neuropathy - Pipeline Review, H2 2016

Diabetic Neuropathy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Diabetic Neuropathy - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy – Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology, Mental Health, Therapy
  • Countries : United States
Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis (Kala-Azar) – Pipeline Review, H2 2016, ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States, World

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.